Abstract Presentations 4. Mariam Maglakelidze, Georgia Breathing - - PowerPoint PPT Presentation

abstract presentations 4 mariam maglakelidze georgia
SMART_READER_LITE
LIVE PREVIEW

Abstract Presentations 4. Mariam Maglakelidze, Georgia Breathing - - PowerPoint PPT Presentation

Abstract Presentations 4. Mariam Maglakelidze, Georgia Breathing and feeling well through universal access to right care A randomized controlled feasibility trial (RCT) of a pulmonary rehabilitation (PR) programme for symptomatic COPD Patients


slide-1
SLIDE 1

Breathing and feeling well through universal access to right care

Abstract Presentations

  • 4. Mariam Maglakelidze, Georgia
slide-2
SLIDE 2

Breathing and feeling well through universal access to right care

A randomized controlled feasibility trial (RCT) of a pulmonary rehabilitation (PR) programme for symptomatic COPD Patients in Georgia: A Breathe Well study

Maglakelidze, N1,3; Jolly, K2; Maglakelidze, M1; Maglakelidze, T1; Chkhaidze, I1; Dickens, A2; Kurua, I1; Gogvadze, K1; Rai2, K; Enocson2, A; Adams, R2; Jordan, R2;; Sitch, A2; Turner, A2; Adab, P2 on behalf of the Breathe Well Group. Presenter: Mariam Maglakelidze Affiliations:

1 Georgian Respiratory Association, Georgia 2 Institute of Applied Health Research, University of Birmingham, Birmingham, UK 3 National Centre for Disease Control and Public Health, Georgia

slide-3
SLIDE 3

Study methods

  • Aim: To assess the feasibility of delivering an RCT of a culturally tailored PR intervention in

Tbilisi, Georgia.

  • Methods: An RCT with qualitative interviews.
  • Population: Symptomatic COPD patients, MRC ≥2, primary/secondary care
  • Intervention: Pulmonary rehabilitation, (pre rehab, PR twice a week. 8 week programme)
  • Control: 2 educational session after final follow-up at 6m
  • Outcome:
  • Feasibility: fidelity, acceptability, recruitment rate, follow-up rate at 6m, adherence,

healthcare use, patient-incurred costs

  • Health outcomes: HRQOL, exercise capacity, smoking status, CAT, physical activity,

anxiety/depression, exacerbations, healthcare use

  • Sample size: n=60 (30 per arm)
  • Research site: 1 hospital (Tbilisi)
slide-4
SLIDE 4

Baseline characteristics, recruitment and follow-up

Follow- up Intervention (n=30) Usual care (n=30) All (n=60) 8 weeks 12 (40.0%) 26 (86.7%) 38 (63.3%) 6 months 27 (90.0%) 26 (86.7%) 53 (88.3%) Baseline Characteristics Intervention (n=30) Control (n=30) Sex; n (%) male 26 (86.7) 28 (93.3) Age in years; mean (SD) 64 (7.3) 65 (8.7) Employment; n (%) in work 7 (23.3) 13 (43.3) ISWT in metres; mean (SD) 229.7 (112.7) 249.3 (96.2) CAT; mean (SD) 20.3 (5.9) 19.9 (6.6) PHQ-9; mean (SD) 6.2 (4.02) 5.33 (4.06) Self-reported exacerbations in last 12m; median (IQR) 2.73 (0.94) 2.3 (1.14)

slide-5
SLIDE 5

Attendance

  • 23 (77%) attended at

least once

  • 13 (43%) attended at

least 70% of sessions

  • Mean sessions attended:

7.8 (sd 6.7)

10 20 30 40 50 60 70 80 90

Pre 1 2 3 4 5 6 7 8 9 10 11 12 15 16

Intervention attendance %

slide-6
SLIDE 6

Secondary outcomes

Baseline 8 week follow-up 6 month follow-up

Intervention N=30 Usual care N=30 Intervention N=12 Usual care N=26 Intervention N=27 Usual care N=26

SGRQ – Impact (SD)

42.02 (19.9) 37.0 (20.3) 23.30 (25.6) 37.58 (23.2) 38.43 (23.6) 30.05 (20.0)

SGRQ – Activity (SD)

67.03 (20.2) 56.92 (24.1) 42.45 (32.9) 58.60 (20.3) 58.48 (29.8) 49.20 (24.8)

SGRQ – Symptoms (SD)

64.17 (17.1) 65.37 (15.0) 40.95 (31,56) 60.47 (25.7) 58.13 (23.4) 57.72 (24.8)

SGRQ – Total (SD)

53.61 (17.2) 48.13 (17.9) 32.30 (27.4) 48.04 (20.8) 48.07 (23.5) 40.82 (20.0)

ISWT (SD)

229.7 (112.7) 249.4 (96.2) 316.2 (134.3) 247.6 (113.5) 217.6 (89.6) 216.0 (99.4)

CAT (SD)

20.3 (5.9) 19.93 (6.6) 13.76 (8,48) 18.32 (7.03) 17.85 (8.52) 17.65 (7.64)

Stanford Self-Efficacy scale (SD)

5.71 (1.9) 6.66 (1.5) 7.76 (1.24) 6.9 (1.52) 6.96 (1.48) 7.28 (1.22)

PHQ-9 (SD)

6.2 (4.0) 5.33 (4.1) 2.76 (1.92) 5.54 (5.09) 4.74 (4.24) 3.80 (3.02)

GAD-7 (SD)

3.53 (3.2) 3.33 (2.8) 1.92 (1.60) 3.32 (3.47) 2.51 (3.28) 2.03 (2.06)

slide-7
SLIDE 7

Qualitative Interviews

Interviewed: 9 intervention participants and 2 rehabilitation specialists Acceptability:

➢ most had positive experience with the exercise, specialists, educational sessions and the booklet;

education sessions and guidance by rehab specialists were highly valued Their experience of the PR programme: range of experiences

➢ Most were content with the PR, some felt the PR did not influence their condition much, and some

emphasized that they felt more joyful: ▪ “During these exercises I was noticing that I felt much better, my breathing was better, I felt more free. I did not have breathlessness” patient. ▪ “Everything was positive. Whatever we were offered was very human and considerate for patients like us. Everything was consistent and acceptable. Despite weakness, I hope I will be able to exercise according to this program in summer” patient Barriers to continuing with the PR programme:

➢ Transport, weather, health condition, money, work related reasons

slide-8
SLIDE 8

Conclusion:

  • A culturally adapted PR programme was feasible to

deliver, acceptable for patients and PR specialists.

  • The rolling out of such programmes, free of charge, was

strongly supported by intervention participants.

slide-9
SLIDE 9

Acknowledgements

Thank you

This research was funded by the National Institute for Health Research (NIHR) NIHR global group on global COPD in primary care, University of Birmingham, (project reference: 16/137/95) using UK aid from the UK Government to support global health research. The views expressed in this presentation are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care.